These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6206536)

  • 41. Variations of intracellular histamine basophil levels after treatment with ketotifen.
    Córdoba H; Fernández M; Santos F; Oehling A
    J Investig Allergol Clin Immunol; 1992; 2(4):187-90. PubMed ID: 1342899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute effect of ketotifen on the dose-response curve of histamine and methacholine in asthma.
    Lisboa C; Moreno R; Cruz E; Barja S; Sanchez I; Moran J; Ferretti R
    Br J Dis Chest; 1985 Jul; 79(3):235-43. PubMed ID: 3893508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
    Sekardi L; Friedberg KD
    Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of the leukotrienes in asthma].
    Underner M; Patte F
    Allerg Immunol (Paris); 1986 Sep; 18(7):5-10. PubMed ID: 2840090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of ketotifen and clenbuterol on beta-adrenergic receptor functions of lymphocytes and on plasma TXB-2 levels of asthmatic patients.
    Huszar E; Herjavecz I; Böszörmenyi-Nagy G; Slapke J; Schreiber J; Debreczeni LA
    Z Erkr Atmungsorgane; 1990; 175(3):141-6. PubMed ID: 1964319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of the presumably leukotriene-dependent component of antigen-induced bronchoconstriction in the guinea pig by piriprost (U-60,257).
    Bach MK; Griffin RL; Richards IM
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):264-6. PubMed ID: 3924840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
    Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
    Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of leukotriene-induced contractions of guinea pig airways: leukotriene C4 has a potent direct action whereas leukotriene B4 acts indirectly.
    Dahlén SE; Hedqvist P; Westlund P; Granström E; Hammarström S; Lindgren JA; Rådmark O
    Acta Physiol Scand; 1983 Aug; 118(4):393-403. PubMed ID: 6314748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketotifen in the treatment of infants and young children with wheezy bronchitis and bronchial asthma.
    el Hefny A; el Beshlawy A; Nour S; Said M
    J Int Med Res; 1986; 14(5):267-73. PubMed ID: 3533675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mast cell mediators in asthma. Clinical uses of the inhibitors.
    Seropian E; Filip V; Iamandescu I
    Allergol Immunopathol (Madr); 1981; Suppl 9():23-7. PubMed ID: 6187197
    [No Abstract]   [Full Text] [Related]  

  • 55. Bronchial asthma induced by mediators produced in vitro by sensitized lymphomonocytes. Protective effect of ketotifen.
    Lech B; Girard JP
    Allergol Immunopathol (Madr); 1987; 15(4):191-4. PubMed ID: 3318348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils.
    Ohmori K; Manabe H; Akuta-Ohnuma K
    Arzneimittelforschung; 1998 Jan; 48(1):43-6. PubMed ID: 9522030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Release of leukotrienes and histamine by the isolated anaphylactic heart.
    Salari H; Pelletier G
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):217-34. PubMed ID: 2449485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Membrane IgE and adenyl cyclase activity in the dynamics of bronchospasm. Ketotifen as a blocker of antigen action.
    Oehling A; Castillo JG; Gamboa PM
    Allergol Immunopathol (Madr); 1990; 18(4):237-40. PubMed ID: 1702264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketotifen induced inhibition of histamine release in a non-IgE model of middle ear effusion.
    Berger G; Berger R; Goldberg A
    Pediatr Allergy Immunol; 2006 Feb; 17(1):43-8. PubMed ID: 16426254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.